Glenn M. Chertow

Publication Details

  • Modeled Urea Distribution Volume and Mortality in the HEMO Study CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Daugirdas, J. T., Greene, T., Depner, T. A., Levin, N. W., Chertow, G. M. 2011; 6 (5): 1129-1138

    Abstract:

    In the Hemodialysis (HEMO) Study, observed small decreases in achieved equilibrated Kt/V(urea) were noncausally associated with markedly increased mortality. Here we examine the association of mortality with modeled volume (V(m)), the denominator of equilibrated Kt/V(urea).Parameters derived from modeled urea kinetics (including V(m)) and blood pressure (BP) were obtained monthly in 1846 patients. Case mix-adjusted time-dependent Cox regressions were used to relate the relative mortality hazard at each time point to V(m) and to the change in V(m) over the preceding 6 months. Mixed effects models were used to relate V(m) to changes in intradialytic systolic BP and to other factors at each follow-up visit.Mortality was associated with V(m) and change in V(m) over the preceding 6 months. The association between change in V(m) and mortality was independent of vascular access complications. In contrast, mortality was inversely associated with V calculated from anthropometric measurements (V(ant)). In case mix-adjusted analysis using V(m) as a time-dependent covariate, the association of mortality with V(m) strengthened after statistical adjustment for V(ant). After adjustment for V(ant), higher V(m) was associated with slightly smaller reductions in intradialytic systolic BP and with risk factors for mortality including recent hospitalization and reductions in serum albumin concentration and body weight.An increase in V(m) is a marker for illness and mortality risk in hemodialysis patients.

    View details for DOI 10.2215/CJN.06340710

    View details for Web of Science ID 000290372600025

    View details for PubMedID 21511841

Stanford Medicine Resources:

Footer Links: